February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu The NDA was submitted by Trevena’s partner, Jiangsu Nhwa Pharmaceutical, and follows completion by Nhwa

Jiang, L.I., et al., Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine

Jianming Han , Tao Che  for their analysis of GPCR-G protein selectivity revealed by structural pharmacology

This week's highlight includes congrats to: Junyi Liang, Niña Caculitan, and Adam W Smith for their research

., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen, Z., Huang, Z., & He, Y. (2022).